Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.

Abstract

These data suggest that oral conjugated estrogen replacement reduces functional ATIII, whereas transdermal estradiol replacement therapy does not modify it.